clenbuterol has been researched along with Neuronal Ceroid-Lipofuscinoses in 1 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Neuronal Ceroid-Lipofuscinoses: A group of severe neurodegenerative diseases characterized by intracellular accumulation of autofluorescent wax-like lipid materials (CEROID; LIPOFUSCIN) in neurons. There are several subtypes based on mutations of the various genes, time of disease onset, and severity of the neurological defects such as progressive DEMENTIA; SEIZURES; and visual failure.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with clenbuterol, a beta(2)-adrenoceptor agonist that can enhance regeneration of motor neuron axons, opposed the development of motor deficits in parallel with a reduced proportion of motor neurons with eccentric nuclei consistent with improved synaptic function." | 1.32 | Clenbuterol retards loss of motor function in motor neuron degeneration mice. ( Etlinger, JD; Peng, H; Zeman, RJ, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zeman, RJ | 1 |
Peng, H | 1 |
Etlinger, JD | 1 |
1 other study available for clenbuterol and Neuronal Ceroid-Lipofuscinoses
Article | Year |
---|---|
Clenbuterol retards loss of motor function in motor neuron degeneration mice.
Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Diagnostic Techniques, Neurological; Disease Models, | 2004 |